C J Gelatine Products Ltd
₹ 18.2
0.33%
28 Mar
- close price
About
Established in 1982, C.J. Gelatine Products Ltd is engaged in the business of manufacturing of Gelatine and related by-products like Di-Calcium Phosphate, Ossein, etc.
Key Points
- Market Cap ₹ 8.77 Cr.
- Current Price ₹ 18.2
- High / Low ₹ 30.5 / 16.4
- Stock P/E 15.7
- Book Value ₹ 12.0
- Dividend Yield 0.00 %
- ROCE 6.39 %
- ROE 3.11 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 26.3 to 20.8 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 9.76% over past five years.
- Company has a low return on equity of 4.01% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12.70 | 15.87 | 14.93 | 17.76 | 22.56 | 16.55 | 23.01 | 25.81 | 28.28 | 39.03 | 39.53 | 36.66 | 39.70 | |
12.17 | 15.22 | 14.66 | 16.47 | 20.86 | 16.66 | 21.84 | 23.91 | 26.59 | 37.15 | 37.46 | 35.06 | 38.01 | |
Operating Profit | 0.53 | 0.65 | 0.27 | 1.29 | 1.70 | -0.11 | 1.17 | 1.90 | 1.69 | 1.88 | 2.07 | 1.60 | 1.69 |
OPM % | 4.17% | 4.10% | 1.81% | 7.26% | 7.54% | -0.66% | 5.08% | 7.36% | 5.98% | 4.82% | 5.24% | 4.36% | 4.26% |
0.02 | 0.03 | 0.24 | 0.00 | 0.10 | 0.18 | 0.23 | -0.16 | 0.06 | 0.02 | 0.04 | 0.59 | -1.73 | |
Interest | 0.34 | 0.46 | 0.51 | 0.87 | 1.32 | 1.74 | 0.96 | 0.86 | 1.13 | 1.07 | 1.22 | 1.37 | 1.42 |
Depreciation | 0.20 | 0.20 | 0.20 | 0.34 | 0.30 | 0.34 | 0.36 | 0.37 | 0.38 | 0.43 | 0.48 | 0.50 | 0.00 |
Profit before tax | 0.01 | 0.02 | -0.20 | 0.08 | 0.18 | -2.01 | 0.08 | 0.51 | 0.24 | 0.40 | 0.41 | 0.32 | -1.46 |
Tax % | 0.00% | 0.00% | 0.00% | 12.50% | 33.33% | 0.00% | 12.50% | 25.49% | 12.50% | 12.50% | 14.63% | 28.12% | |
0.01 | 0.02 | -0.20 | 0.06 | 0.13 | -2.01 | 0.06 | 0.37 | 0.22 | 0.35 | 0.35 | 0.23 | -1.54 | |
EPS in Rs | 0.02 | 0.04 | -0.42 | 0.12 | 0.27 | -4.18 | 0.12 | 0.77 | 0.46 | 0.73 | 0.73 | 0.48 | -3.20 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 10% |
3 Years: | 9% |
TTM: | 4% |
Compounded Profit Growth | |
---|---|
10 Years: | 28% |
5 Years: | 31% |
3 Years: | 1% |
TTM: | 195% |
Stock Price CAGR | |
---|---|
10 Years: | 1% |
5 Years: | 17% |
3 Years: | 9% |
1 Year: | -15% |
Return on Equity | |
---|---|
10 Years: | 0% |
5 Years: | 4% |
3 Years: | 4% |
Last Year: | 3% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 | 4.81 |
Reserves | 9.62 | 9.07 | 8.31 | 7.74 | 7.30 | 4.73 | 4.22 | 4.03 | 3.69 | 2.97 | 2.75 | 2.42 | 0.97 |
2.04 | 2.04 | 1.64 | 1.83 | 6.00 | 7.68 | 5.37 | 5.01 | 9.93 | 12.83 | 18.57 | 19.55 | 17.80 | |
6.45 | 7.08 | 6.92 | 9.41 | 9.78 | 14.68 | 17.69 | 17.05 | 12.56 | 11.95 | 8.67 | 8.68 | 7.82 | |
Total Liabilities | 22.92 | 23.00 | 21.68 | 23.79 | 27.89 | 31.90 | 32.09 | 30.90 | 30.99 | 32.56 | 34.80 | 35.46 | 31.40 |
12.00 | 11.25 | 10.51 | 9.54 | 9.48 | 9.26 | 8.66 | 8.04 | 7.42 | 7.09 | 7.27 | 7.15 | 7.51 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
10.92 | 11.75 | 11.17 | 14.25 | 18.41 | 22.64 | 23.43 | 22.86 | 23.57 | 25.47 | 27.53 | 28.31 | 23.89 | |
Total Assets | 22.92 | 23.00 | 21.68 | 23.79 | 27.89 | 31.90 | 32.09 | 30.90 | 30.99 | 32.56 | 34.80 | 35.46 | 31.40 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.70 | 0.20 | 0.92 | 0.69 | 0.78 | 1.11 | 2.15 | 1.30 | -6.19 | -3.34 | -4.07 | 0.80 | |
-0.11 | -0.02 | -0.03 | 0.00 | -0.80 | -0.68 | -0.33 | -0.32 | -0.26 | -0.65 | -1.18 | -0.36 | |
-1.12 | -0.44 | -0.90 | -0.68 | 1.58 | -0.47 | -3.25 | -0.59 | 6.01 | 3.98 | 4.50 | -0.45 | |
Net Cash Flow | -1.93 | -0.26 | -0.01 | 0.01 | 1.56 | -0.04 | -1.42 | 0.40 | -0.43 | -0.01 | -0.75 | -0.01 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 11.50 | 31.51 | 19.80 | 29.59 | 33.01 | 77.85 | 67.57 | 53.88 | 31.62 | 23.94 | 34.26 | 20.81 |
Inventory Days | 591.89 | 342.60 | 421.33 | 424.77 | 375.37 | 629.85 | 430.58 | 395.32 | 414.65 | 275.60 | 274.00 | 326.45 |
Days Payable | 291.01 | 228.27 | 274.43 | 301.12 | 247.26 | 514.05 | 399.89 | 352.31 | 233.33 | 129.87 | 75.28 | 78.02 |
Cash Conversion Cycle | 312.37 | 145.84 | 166.70 | 153.25 | 161.12 | 193.65 | 98.26 | 96.89 | 212.93 | 169.68 | 232.97 | 269.25 |
Working Capital Days | 120.71 | 106.95 | 103.41 | 98.65 | 93.19 | 103.88 | 62.34 | 47.94 | 130.23 | 111.66 | 166.66 | 185.98 |
ROCE % | 2.04% | 2.96% | 0.65% | 7.55% | 9.05% | -1.75% | 6.58% | 10.97% | 8.49% | 7.53% | 6.97% | 6.39% |
Documents
Announcements
- Closure of Trading Window 24h
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
15 Feb - Read with Regulations 46 and 30 of the SEBI (LODR) Regulations, 2015 (as amended), please find attached herewith the details which same have published in …
- Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2023 Along With Limited Review Report As Received From The Statutory Auditors Of The Company. 14 Feb
- Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2023 Along-With Limited Review Report, 14 Feb
- Board Meeting Intimation for Meeting To Be Held On Wednesday, February 14, 2024, Inter Alia To Consider And Approve The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2023 Along With The Limited Review Report. 3 Feb
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Product Overview:[1]
Gelatin is the main ingredient in empty capsules and soft-gel capsules. As a rich source of protein, Gelatin finds application in numerous end use sectors including pharma, food and beverage, photographic supplies, cosmetics, explosives, electroplating, dyes, papermaking and printing.
Gelatin capsules hold major market share in empty capsule markets. Gelatin provides rapid drug release and excellent oxygen barrier and hence are preferred for manufacturing capsule shells.